Literature review and analysis of adverse drug reactions of anlotinib
10.12206/j.issn.1006-0111.202007073
- VernacularTitle:安罗替尼上市后不良反应文献回顾性分析
- Author:
Xiaolan LIAO
1
,
2
;
Ying WANG
3
;
Aiwen HUANG
3
;
Yanlan LAI
1
,
2
;
Lijun ZHAO
1
,
2
;
Hongtao SONG
4
Author Information
1. Department of Clinical Pharmacy
2. College of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China.
3. Department of Clinical Pharmacy.
4. Department of Pharmacy, No. 900 Hospital of Joint Logistics Support Force of the PLA, Fuzhou 350025, China.
- Keywords:
anlotinib;
adverse drug reactions;
retrospective analysis
- From:
Journal of Pharmaceutical Practice
2020;38(6):558-562
- CountryChina
- Language:Chinese
-
Abstract:
Objective To review and analysis the clinical manifestations, occurrence rules, treatment and outcomes of adverse drug reactions caused by anlotinib in order to provide reference for safety and reasonable use of anlotinib in clinical practice. Methods The cases reports of anlotinib were searched in Web of Science, Pubmed, Wiley Online Library, CNKI, Wanfang and VIP. The basic patient information, adverse reaction time, characters, treatment, outcomes and involved systems or organs were collected and analyzed. Results A total of 20 cases were collected, 10 females and 10 males, with a median age of 63.5(36~76 years old). Adverse drug reactions mostly occurred within 2 months after the medication. 52 cases occurred in total, involving 9 systems/organs, of which blood and lymphatic system disorders (all were hypertension) were the most common (21.2%). Conclusion After the administration of anlotinib, the incidence rate of adverse reactions in the cardiovascular system is relatively high. The medication process should be closely monitored, and attention should be paid to monitoring the potential adverse reactions mentioned in the instructions.